CHI3L2 and depressive symptom measurement: With regard to alterations of the BBB, Feng et al. reviewed evidence demonstrating BBB changes in depression and schizophrenia, highlighting a potential role of the inflammatory pathway and CHI3L2 in the pathology of both LOAD and MDD [48].